5-ethyl-4-methyl-6-(1-pyrrolidinyl)-2-pyrimidinamine, 95.0%, 1g

(2-Bromo-6-fluorophenyl)boronic acid, 95.0%, 5g

2-Isopropyl-4-methoxyphenyl boronic acid, 95%, 500mg

1,2:5,6-Bis-o-(1-methylethylidene)-D-mannitol, 95.0%, 500g

3-(TRIFLUOROMETHYL)CYCLOBUTAN-1-OL, 95.0%, 100mg

5-bromo-4-fluoro-1H-pyrazole, 97%, 10g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

1-Methyl-3-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]-2-pyridyl]amino]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-one, 97%, 1g

2-Methylbenzo[d]oxazol-6-amine, 95.0%, 1g

3-(3,5-Dimethoxybenzoyl)quinoline, 97.0%, 1g

Copper Target 99.99% dia. 25.4 mm x 6.35 mm 1 pc

7-phenyl-2-pyrrolidin-1-yl[1,3]thiazolo[4,5-d]pyridazin-4(5H)-one, 95.0%, 500mg

1-(4-Fluoro-phenyl)-1H-pyrazole-4-carboxylic acid, 99%, 5g